Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Lack of vitamin D receptor causes hair loss in mice by allowing certain genes to overactivate.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Different wool coat types in goats are linked to specific gene expressions, which could improve cashmere quality.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Mettl3 is essential for normal tissue development and self-renewal by regulating gene expression.

CD2 might be a new treatment target for patchy alopecia areata.

FOXN1 gene variants cause low T cells and immune issues from birth.

Using special RNA to target a mutant gene fixed hair problems in mice.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Injecting lentiviral vectors into early gestation mice effectively targets skin stem cells for potential gene therapy.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

Alopecia areata involves specific immune cells, offering potential treatment targets.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Hairless protein affects hair follicle structure by regulating the Dlx3 gene.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Overexpression of Hoxc13 in hair cells causes hair loss and skin issues.

Staphylococcus aureus delays wound healing by disrupting lipid metabolism in skin cells.

Androgen receptors help prostate cancer cells grow and resist drugs.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

The transcription factor Meis2 is essential for touch sensation and proper nerve development in touch receptors.